Adenoviral VEGF-D(ΔN ΔC) gene therapy for myocardial ischemia

Background: Cardiovascular diseases are the leading cause of death globally. In spite of the availability of improved treatments, there is still a large group of chronic ischemia patients who suffer from significant symptoms and disability. Thus, there is a clear need to develop new treatment strate...

Descripción completa

Detalles Bibliográficos
Autores principales: Pajula, Juho, Lähteenvuo, Johanna, Lähteenvuo, Markku, Honkonen, Krista, Halonen, Paavo, Hätinen, Olli-Pekka, Kuivanen, Antti, Heikkilä, Minja, Nurro, Jussi, Hartikainen, Juha, Ylä-Herttuala, Seppo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817830/
https://www.ncbi.nlm.nih.gov/pubmed/36619378
http://dx.doi.org/10.3389/fbioe.2022.999226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817830/
https://www.ncbi.nlm.nih.gov/pubmed/36619378
http://dx.doi.org/10.3389/fbioe.2022.999226

Ejemplares similares